Projected Income Statement: Xylem Inc.

Forecast Balance Sheet: Xylem Inc.

Forecast Balance Sheet - Xylem Inc.
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 1,091 936 1,265 895 463 1,319 441 -570
Change - -14.21% 35.15% -29.25% -48.27% 184.88% -66.57% -229.25%
Announcement Date 2/3/22 2/7/23 2/6/24 2/4/25 2/10/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Xylem Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 208 208 271 321 331 354.2 362.8 376.8
Change - 0% 30.29% 18.45% 3.12% 7.02% 2.43% 3.87%
Free Cash Flow (FCF) 1 330 388 599 942 910 944.9 1,280 1,521
Change - 17.58% 54.38% 57.26% -3.4% 3.83% 35.48% 18.85%
Announcement Date 2/3/22 2/7/23 2/6/24 2/4/25 2/10/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Xylem Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 16.48% 16.44% 18.9% 20.59% 22.24% 23.24% 23.97% 24.83%
EBIT Margin (%) 11.76% 12.17% 14.56% 16.04% 17.84% 18.87% 19.77% 20.66%
EBT Margin (%) 9.84% 7.97% 8.62% 12.7% 13.07% 15.23% 17.07% 18.15%
Net margin (%) 8.22% 6.43% 8.27% 10.39% 10.59% 11.74% 13.23% 14.16%
FCF margin (%) 6.35% 7.03% 8.13% 11% 10.07% 10.28% 13.32% 15.04%
FCF / Net Income (%) 77.28% 109.3% 98.36% 105.84% 95.09% 87.59% 100.7% 106.27%

Profitability

        
ROA 5.02% 4.38% 5.06% 5.46% 5.61% 6.89% 7.65% 7.92%
ROE 13.81% 15.38% 12.08% 9.8% 11.21% 12.02% 12.87% 13.31%

Financial Health

        
Leverage (Debt/EBITDA) 1.27x 1.03x 0.91x 0.51x 0.23x 0.62x 0.19x -
Debt / Free cash flow 3.31x 2.41x 2.11x 0.95x 0.51x 1.4x 0.34x -

Capital Intensity

        
CAPEX / Current Assets (%) 4% 3.77% 3.68% 3.75% 3.66% 3.86% 3.78% 3.73%
CAPEX / EBITDA (%) 24.3% 22.91% 19.47% 18.21% 16.48% 16.59% 15.76% 15.01%
CAPEX / FCF (%) 63.03% 53.61% 45.24% 34.08% 36.37% 37.49% 28.34% 24.77%

Items per share

        
Cash flow per share 1 2.96 3.293 3.836 5.206 5.086 7 8.01 8.79
Change - 11.24% 16.49% 35.72% -2.31% 37.63% 14.43% 9.74%
Dividend per Share 1 1.12 1.2 1.32 1.44 1.6 1.709 1.838 1.99
Change - 7.14% 10% 9.09% 11.11% 6.79% 7.57% 8.29%
Book Value Per Share 1 17.84 19.38 42.08 43.79 47.05 45.75 49.08 51.78
Change - 8.65% 117.08% 4.08% 7.43% -2.77% 7.28% 5.5%
EPS 1 2.35 1.96 2.79 3.65 3.92 4.55 5.349 6.109
Change - -16.6% 42.35% 30.82% 7.4% 16.06% 17.57% 14.22%
Nbr of stocks (in thousands) 180,325 180,222 241,078 242,945 243,469 233,487 233,487 233,487
Announcement Date 2/3/22 2/7/23 2/6/24 2/4/25 2/10/26 - - -
1USD
Estimates
2026 *2027 *
P/E 23.9x 20.3x
PBR 2.38x 2.22x
EV / Sales 2.91x 2.69x
Yield 1.57% 1.69%

EPS & Dividend

EPS & Dividend - Xylem Inc.


Y-o-Y evolution of P/E

Valuation ratios - P/E - Xylem Inc.
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Xylem Inc.
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Xylem Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
108.74USD
Average target price
142.62USD
Spread / Average Target
+31.16%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Xylem Inc.
  1. Stock Market
  2. Stocks
  3. XYL Stock
  4. Financials Xylem Inc.